Anti-CCL17 antibodies
US11414484B2 · kind B2 · utility
0Cited by
25References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 1, 2020 |
| Grant date | Aug 16, 2022 |
| Priority date | — |
| Expiry date | Feb 3, 2041 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to antibodies specifically binding CCL17, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.